Atlas Trials

Metronomic Treatment in Children and Adolescents With Recurrent or Progressive High Risk Neuroblastoma

Clinical trial NCT02641314 · COMPLETED

Trial details

NCT number
NCT02641314
Sponsor
University of Cologne
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Neuroblastoma
Start date
2016-12-22
Primary completion
2023-06-29
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.